Edition:
India

PLx Pharma Inc (PLXP.OQ)

PLXP.OQ on NASDAQ Stock Exchange Capital Market

6.60USD
19 Jan 2018
Change (% chg)

$0.60 (+10.00%)
Prev Close
$6.00
Open
$6.40
Day's High
$6.70
Day's Low
$6.30
Volume
53,094
Avg. Vol
4,891
52-wk High
$12.80
52-wk Low
$5.60

Chart for

About

PLx Pharma Inc., formerly Dipexium Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325... (more)

Overall

Beta: 1.85
Market Cap(Mil.): $55.17
Shares Outstanding(Mil.): 8.69
Dividend: --
Yield (%): --

Financials

BRIEF-Park West Asset Management reports 12.3 pct stake in PLx Pharma

* Park West Asset Management Llc reports 12.3 percent stake in PLx Pharma Inc ‍​as of November 20 - SEC filing

21 Nov 2017

BRIEF-PLx Pharma Inc. Reports third quarter 2017 results

* Q3 loss per share $0.44 Source text for Eikon: Further company coverage:

10 Nov 2017

BRIEF-PLx Pharma reports Q2 loss per share $0.36

* Q2 loss per share $0.36 Source text for Eikon: Further company coverage:

11 Aug 2017

BRIEF-Plx Pharma, unit entered a loan and security agreement

* Plx Pharma - ‍on Aug 9, co and its unit entered a loan and security agreement with Silicon Valley Bank​

10 Aug 2017

Earnings vs. Estimates